Publications by authors named "Saraporn Matayart"
Article Synopsis
- Hypokalemia in peritoneal dialysis (PD) patients is linked to higher risks of peritonitis and mortality, but the effects of potassium correction on these outcomes are unclear.
- The study involved a multicenter trial comparing protocol-based potassium supplementation with conventional supplementation in adults with hypokalemia over 52 weeks.
- Results showed that the protocol-based group had significantly higher serum potassium levels and a longer time to the first peritonitis episode compared to the conventional group.
Intraperitoneal Cefepime Monotherapy Versus Combination Therapy of Cefazolin Plus Ceftazidime for Empirical Treatment of CAPD-Associated Peritonitis: A Multicenter, Open-Label, Noninferiority, Randomized, Controlled Trial.
Thidarat Kitrungphaiboon Pongpratch Puapatanakul Piyatida Chuengsaman Krittaya Tiskajornsiri Guttiga Halue Saraporn Matayart
Am J Kidney Dis
November 2019
Rationale & Objective: Compared to combination therapy, intraperitoneal (IP) cefepime monotherapy for continuous ambulatory peritoneal dialysis (CAPD)-associated peritonitis may provide potential benefits in lowering staff burden, shortening time-consuming antibiotic preparation, and reducing bag contamination risk. This study sought to evaluate whether cefepime monotherapy is noninferior to combination regimens.
Study Design: Multicenter, open-label, noninferiority, randomized, controlled trial.